Description
A multi-targeted RTK inhibitor that inhibits c-Kit, PDGFRα, and c-Met (IC50s = 10, 40, and 81 nM, respectively); sensitizes cancer cells to radiation and chemotherapeutic compounds, in part by inhibiting homologous recombination
Formal name: N-(1,3-benzodioxol-5-ylmethyl)-4-benzofuro[3,2-d]pyrimidin-4-yl-1-piperazinecarbothioamide
Synonyms: HPK56|MP470
Molecular weight: 447.5
CAS: 850879-09-3
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Kinase Inhibitors|Other Receptor Tyrosine Kinases||Product Type|Biochemicals|Kinase Inhibitors|PDGFR Family||Product Type|Biochemicals|Small Molecule Inhibitors|Kinases||Research Area|Cancer|Cell Death|Apoptosis||Research Area|Cancer|Cell Signaling|Growth Factor Receptor Signaling